Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Contact immunotherapy helped hair regrow in a patient with both alopecia and psoriasis.

Gut bacteria differences may influence alopecia areata.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Monoclonal antibodies are often linked to alopecia areata cases.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Telemedicine is effective for managing alopecia areata follow-ups.

People with alopecia who are more resilient tend to feel less stressed.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Baricitinib is effective and safe for treating alopecia areata in Korea.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Routine eye exams may be needed for alopecia areata patients due to common eye issues.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

People with Alopecia Areata have a higher risk of heart-related health issues.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

Antioxidants can help improve hair growth in people with alopecia areata.

More severe alopecia areata can lower quality of life.

Nail changes are common in alopecia areata and can indicate its severity.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Lower vitamin D levels are linked to more severe alopecia areata.